Voyager Therapeutics, Inc. (VYGR)

NASDAQ: VYGR · IEX Real-Time Price · USD

7.50

-0.05 (-0.66%)

At close: Apr 19, 2024, 4:00 PM

7.53

+0.03 (0.40%)

After-hours: Apr 19, 2024, 4:51 PM EDT

Voyager Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Net Income	132.33	-46.41	-71.2	36.74	-43.6	-88.29	-70.7	-40.19	-38.29	-17.68
Depreciation & Amortization	4.44	6.19	5.17	3.82	2.77	2.12	1.6	0.61	0.6	0.18
Share-Based Compensation	11.15	9.34	11.32	14.93	15.64	15.71	9.24	6.31	4.03	0.68
Other Operating Activities	-70.01	18.36	1.18	-152.21	73.86	54.57	-1.49	-9.21	66.34	3.54
Operating Cash Flow	77.92	-12.51	-53.53	-96.72	48.67	-15.89	-61.35	-42.48	41.3	-11.92
Capital Expenditures	-3.26	-2.49	-1.61	-12.1	-7.55	-4.31	-3.99	-5.03	-1.03	-2.99
Change in Investments	-138.39	-4.85	67.52	125.09	-82.93	30.77	0.3	52.75	-193.74	0
Other Investing Activities	-	-	-	-	-	-	-	-	-	-0.31
Investing Cash Flow	-141.64	-7.34	65.91	113	-90.48	26.47	-3.68	47.72	-194.77	-3.3
Share Issuance / Repurchase	33.65	1.11	0.61	3.16	80.99	4.75	59.92	0.51	177.74	0.08
Other Financing Activities	-	-	-	-	-	-	-	-	-	22.04
Financing Cash Flow	33.65	1.11	0.61	3.16	80.99	4.75	59.92	0.51	177.74	22.12
Net Cash Flow	-30.08	-18.74	12.99	19.44	39.18	15.33	-5.11	5.75	24.27	6.9
Free Cash Flow	74.66	-15	-55.13	-108.81	41.12	-20.19	-65.34	-47.51	40.27	-14.91
Free Cash Flow Margin	29.86%	-36.67%	-147.36%	-63.59%	39.39%	-265.02%	-644.65%	-334.11%	232.31%	-
Free Cash Flow Per Share	1.74	-0.39	-1.46	-2.93	1.15	-0.63	-2.44	-1.88	9.61	-23.46

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).